Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-10-02
2007-10-02
Li, Q. Janice (Department: 1633)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C435S069100, C435S320100
Reexamination Certificate
active
10296555
ABSTRACT:
The present invention relates to: pharmaceutical compositions for inducing apoptosis in cells, the pharmaceutical compositions comprising a prostacyclin synthase gene as an active ingredient; pharmaceutical compositions for gene therapy of cancer, the pharmaceutical compositions comprising the above pharmaceutical compositions for inducing apoptosis as an active ingredient; and a screening method for an agent that induces apoptosis in a cell, the method comprising determining the activation of peroxisome proliferator-activated receptor (PPAR)-δ in the presence of a test substance. The pharmaceutical composition of the present invention for inducing apoptosis enables treatment of diseases on which induction of apoptosis has a therapeutic effect. In addition, the pharmaceutical composition of the present invention for gene therapy can lead cancer cells to cell death. Furthermore, the screening method of the present invention can be used conveniently to screen for agents capable of inducing apoptosis.
REFERENCES:
patent: 5814509 (1998-09-01), Tanabe
patent: WO96/40128 (1996-12-01), None
patent: WO99/00491 (1999-01-01), None
Kinoshita et al, Biochim Biophys Acta 1999; 1438: 120-30.
Okahara et al, Arterioscler Thromb Vasc Biol 1998; 18: 1922-6.
Crew et al, Carcinogen 2000;2:69-77.
Tsujii et al, PNAS 1997;94:3336-40.
Keith et al, FASEB J Mar. 15, 2000; 14(4):A474.
Keith et al, Cancer Res 2002;62:734-40.
Keith et al, Am J Respiratory Crit Care Med Mar. 1999; 159, No. 3, Supp. A206, (Best copy available).
Bunn et al, The future of cyclooxygenase-2 inhibitors and other inhibitors of the eicosanoid signal pathway in the prevention and thearpy of lung cancer. Clin Lung Cancer 2002;3:271-277.
Hatae, et al., The Molecular Biology Society of Japan, 22nd Annual Meeting, “A New Physiological Activity of Prostacyclin: G Protein Coupled Receptor (IP)-independent Pathway”, pp. 268 (W41-5), (1999).
Bishop-Bailey, et al., “Endothelial Cell Apoptosis Induced by the Peroxisome Proliferator-activated Receptor (PPAR) Ligand 15-Deoxy-Δ12,14-prostaglandin J2”, vol. 274, No. 24, pp. 17042-17048 (1999).
Iwai, et al., “Human Prostacyclin Synthase Gene and Hypertension—The Suita Study”, Circulation, vol. 100, pp. 2231-2236 (1999).
Numaguchi, et al., “Prostacyclin Synthase Gene Transfer Accelerates Reendothelialization and Inhibits Neointimal Formation in Rat Carotid Arteries After Balloon Injury”, Arterioscler Thromb Vasc Biol., vol. 19, pp. 727-733 (1999).
Todaka, et al., “Gene Transfer of Human Protacyclin Synthase Prevents Neointimal Formation After Carotid Balloon Injury in Rats”, Stoke, vol. 30, pp. 419-426 (1999).
He, et al., “PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs”, Cell, vol. 99, pp. 335-345 (1999).
Dusting, et al., “Nitric Oxide in Atherosclerosis: Vascular Protector or Villain?”, Clin Exp Pharmacol Physiol Suppl, vol. 25, pp. S34-S41 (1998).
Kroll, et al., “Inhibition of Transforming Growth Factor-β1 and UV Light-Induced Apoptosis by Prostanoids in Prmary Cultures of Rat Hepatocytes”, Toxicol Appl Pharmacol, vol. 152, pp. 240-250 (1998).
Hatae Toshihisa
Tanabe Tadashi
Li Q. Janice
Tanabe Tadashi
Townsend and Townsend / and Crew LLP
LandOfFree
Medicinal compositions containing prostacylin synthase gene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medicinal compositions containing prostacylin synthase gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicinal compositions containing prostacylin synthase gene will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3900212